Xiangcai Co

Xiangcai Co Inventory

The Inventory of Xiangcai Co (600095.SS) as of Oct 20, 2026 is 11.08 M CNY. In the previous year, Inventory was 29.06 M CNY — a change of -61.87% (lower).

Inventory

11.08 MCNY

YoY

-61.87%

Last updated:

Inventory of Xiangcai Co is 2025 11.08 M CNY. Inventory of Xiangcai Co was 2024 29.06 M CNY. It decreases by -61.87% lower compared to the previous year.

The Xiangcai Co Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
210.07 M CNY
Jan 1, 2019
198.02 M CNY
Jan 1, 2020
17.57 M CNY
Jan 1, 2021
18.60 M CNY
Jan 1, 2022
15.91 M CNY
Jan 1, 2023
12.59 M CNY
Jan 1, 2024
29.06 M CNY
Jan 1, 2025
11.08 M CNY
The Xiangcai Co Inventory history
YEARInventoryYoY
11.08 MCNY-61.87%
29.06 MCNY+130.83%
12.59 MCNY-20.84%
15.91 MCNY-14.48%
18.60 MCNY+5.87%
17.57 MCNY-91.13%
198.02 MCNY-5.74%
210.07 MCNY-23.42%
274.32 MCNY-18.74%
337.58 MCNY-21.80%
431.71 MCNY-7.70%
467.70 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xiangcai Co Stock analysis

What does Xiangcai Co do? Xiangcai Co., Ltd. generates revenue through multiple business segments including non-GMO soybean products processing, pharmaceuticals, waterproof membrane manufacturing, and industrial plants. The company produces soybean protein isolate, soybean tissue protein, and soybean nutritious food under its soybean deep processing division. Its pharmaceutical segment focuses on thymopeptide enteric-coated tablets and other immune system treatment drugs. The waterproof membrane business manufactures and sells polyethylene polypropylene fiber coils, load-bearing coils, and joint profiles. Real estate development and property management contribute to the company's revenue through residential and industrial real estate projects. The primary buyers for soybean deep processing products include food manufacturers and health supplement companies seeking non-GMO ingredients. Pharmaceutical customers consist of hospitals, pharmacies, and healthcare providers purchasing thymopeptide enteric-coated tablets for immune system treatments. Waterproof membrane products are sold to construction companies and building contractors for infrastructure and residential projects. Real estate clients are residential buyers and industrial tenants requiring property development and management services. Xiangcai Co., Ltd. serves distinct market segments: food and beverage manufacturers for soybean products, healthcare institutions for pharmaceuticals, construction firms for waterproofing solutions, and residential/industrial property occupants for real estate services. The company's product portfolio spans from raw material processing to end-user applications across these sectors, creating diversified revenue streams. Xiangcai Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xiangcai Co stock

Inventory of Xiangcai Co is 11.08 M CNY in 2025.

Inventory of Xiangcai Co changed from 29.06 M CNY to 11.08 M CNY, representing a -61.87% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Xiangcai Co since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Xiangcai Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Xiangcai Co

All Key Metrics — Xiangcai Co